The Neuroscience Report—Volume 39 (April 11, 2016): Rapid-acting Antidepressants

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Rapid-acting Antidepressants Journal Articles Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Neurobiology of Stress, Depression, and Rapid Acting Antidepressants: Remodeling Synaptic Connections Circadian Dysregulation of Clock Genes: Clues to Rapid Treatments in Major Depressive Disorder Ketamine and Other N-methyl-D-aspartate Receptor Antagonists in the Treatment of Depression: A Perspective Review News Articles Scientists Seek Fast-acting Antidepressant, from Ketamine to Laughing Gas Five New NMDA Receptor (Glutamate) Modulators For Depression Rapastinel: A Novel Approach to Depression? The Search for a “Safer” Ketamine Novel Route for Ketamine in the Treatment of MDD Wildcards 20 New Antidepressants In The Pipeline (2015): Drugs In Clinical Trials Depression: My Story About the Power of Medication Why We’ve Probably Overestimated the Benefits of Psychotherapy for Depression The Mental Illness Drunk Tank Ketamine: Life Saver...
Source: Innovations in Clinical Neuroscience - Category: Neuroscience Authors: Tags: Drug Development Mood Disorders Psychiatry Psychopharmacology The Neuroscience Report glutamate Ketamine N-methyl-D-aspartate NMDA rapid acting antidepressant Source Type: research